title: Relapse of posttraumatic osteomyelitis due to Clostridium celerecrescens.
authors.forename: A
authors.initials: A
authors.lastname: Mischnik
authors.forename: S
authors.initials: S
authors.lastname: Zimmermann
authors.forename: I
authors.initials: I
authors.lastname: Bekeredjian-Ding
authors.forename: M
authors.initials: M
authors.lastname: Egermann
mesh_terms: D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002444:Cefuroxime / Q000627:therapeutic use; D002908:Chronic Disease; D002981:Clindamycin / Q000627:therapeutic use; D003013:Clostridium / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D003015:Clostridium Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D005858:Germany; D006801:Humans; D007262:Infusions, Intravenous; D008279:Magnetic Resonance Imaging; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D008875:Middle Aged; D010019:Osteomyelitis / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control*; D011859:Radiography; D012008:Recurrence; D013977:Tibia / Q000000981:diagnostic imaging / Q000382:microbiology / Q000473:pathology*; D013978:Tibial Fractures / Q000000981:diagnostic imaging / Q000382:microbiology / Q000473:pathology / Q000628:therapy*
chemical_list: D000900:Anti-Bacterial Agents; D008795:Metronidazole; D002981:Clindamycin; D002444:Cefuroxime